Volume | 469,849 |
|
|||||
News | - | ||||||
Day High | 1.6366 | Low High |
|||||
Day Low | 1.53 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Milestone Pharmaceuticals Inc | MIST | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.60 | 1.53 | 1.6366 | 1.54 | 1.58 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
923 | 469,849 | US$ 1.56 | US$ 734,379 | - | 1.33 - 4.44 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:55:09 | formt | 130 | US$ 1.58 | USD |
Milestone Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
51.56M | 33.48M | - | 1M | -59.69M | -1.78 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Milestone Pharmaceuticals News
Date | Time | Source | News Article |
---|---|---|---|
3/04/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
3/01/2024 | 15:52 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
2/29/2024 | 06:00 | GlobeNewswire Inc. | Milestone Pharmaceuticals Announces Pricing of $30.0 Million.. |
2/28/2024 | 15:37 | GlobeNewswire Inc. | Milestone Pharmaceuticals Announces Proposed Public Offering.. |
2/26/2024 | 06:06 | Edgar (US Regulatory) | Form 8-K - Current report |
2/14/2024 | 19:56 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
2/14/2024 | 06:10 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
12/26/2023 | 07:54 | Dow Jones News | Milestone Pharmaceuticals Shares Sink 24% After Receiving.. |
12/26/2023 | 06:57 | Dow Jones News | Milestone Pharmaceuticals' Etripamil Nasal Spray Application.. |
12/26/2023 | 06:15 | Edgar (US Regulatory) | Form 8-K - Current report |
11/21/2023 | 06:00 | PR Newswire (US) | Milestone Pharmaceuticals to Present at the Piper Sandler.. |
11/13/2023 | 06:05 | Edgar (US Regulatory) | Form 8-K - Current report |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MIST Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.65 | 1.72 | 1.50 | 1.62 | 90,936 | -0.07 | -4.24% |
1 Month | 1.78 | 1.87 | 1.50 | 1.72 | 144,334 | -0.20 | -11.24% |
3 Months | 1.68 | 2.40 | 1.36 | 1.73 | 333,607 | -0.10 | -5.95% |
6 Months | 2.45 | 3.52 | 1.33 | 1.95 | 303,682 | -0.87 | -35.51% |
1 Year | 3.78 | 4.44 | 1.33 | 2.28 | 202,081 | -2.20 | -58.20% |
3 Years | 5.83 | 9.8465 | 1.33 | 4.54 | 182,950 | -4.25 | -72.90% |
5 Years | 15.61 | 27.73 | 1.33 | 6.50 | 493,919 | -14.03 | -89.88% |
Milestone Pharmaceuticals Description
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. |